A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations.

Autor: Saldana-Guerrero IM; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Neuroscience Institute, The University of Sheffield, Sheffield, UK.; Sheffield Institute for Nucleic Acids (SInFoNiA), School of Medicine and Population Health, The University of Sheffield, Sheffield, UK., Montano-Gutierrez LF; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Boswell K; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Neuroscience Institute, The University of Sheffield, Sheffield, UK., Hafemeister C; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Poon E; Division of Clinical Studies, The Institute of Cancer Research (ICR) & Royal Marsden NHS Trust, London, UK., Shaw LE; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Stavish D; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Neuroscience Institute, The University of Sheffield, Sheffield, UK., Lea RA; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Neuroscience Institute, The University of Sheffield, Sheffield, UK., Wernig-Zorc S; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Bozsaky E; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Fetahu IS; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Medical University of Vienna, Department of Neurology, Division of Neuropathology and Neurochemistry, Vienna, Austria., Zoescher P; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Pötschger U; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Bernkopf M; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Labdia Labordiagnostik GmbH, Vienna, Austria., Wenninger-Weinzierl A; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Sturtzel C; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Souilhol C; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Neuroscience Institute, The University of Sheffield, Sheffield, UK.; Biomolecular Sciences Research Centre, Department of Biosciences and Chemistry, Sheffield Hallam University, Sheffield, UK., Tarelli S; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Neuroscience Institute, The University of Sheffield, Sheffield, UK., Shoeb MR; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Bozatzi P; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Rados M; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Guarini M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Buri MC; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Weninger W; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Putz EM; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Huang M; Children's Hospital Los Angeles, Cancer and Blood Disease Institutes, and The Saban Research Institute, Los Angeles, CA, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Ladenstein R; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Andrews PW; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK., Barbaric I; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Neuroscience Institute, The University of Sheffield, Sheffield, UK., Cresswell GD; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Bryant HE; Sheffield Institute for Nucleic Acids (SInFoNiA), School of Medicine and Population Health, The University of Sheffield, Sheffield, UK., Distel M; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Chesler L; Division of Clinical Studies, The Institute of Cancer Research (ICR) & Royal Marsden NHS Trust, London, UK., Taschner-Mandl S; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria., Farlik M; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Tsakiridis A; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK. a.tsakiridis@sheffield.ac.uk.; Neuroscience Institute, The University of Sheffield, Sheffield, UK. a.tsakiridis@sheffield.ac.uk., Halbritter F; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria. florian.halbritter@ccri.at.

Publikováno v: Nature communications [Nat Commun] 2024 May 03; Vol. 15 (1), pp. 3745. Date of Electronic Publication: 2024 May 03.

Identification of germline monoallelic mutations in IKZF2 in patients with immune dysregulation.

Autor: Shahin T; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria., Mayr D; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Shoeb MR; St. Anna Children's Cancer Research Institute, Vienna, Austria., Kuehn HS; Immunology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Hoeger B; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Giuliani S; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria., Gawriyski LM; Proteomics Unit, Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland., Petronczki ÖY; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Hadjadj J; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM Unité Mixte de Recherche (UMR) 1163, Institut Imagine, Université de Paris, Paris, France., Bal SK; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Zoghi S; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.; Network of Immunity in Infection, Malignancy and Autoimmunity, Universal Scientific Education and Research Network, Tehran, Iran., Haimel M; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Jimenez Heredia R; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria., Boutboul D; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, INSERM UMR 1163, Institut Imagine, Université de Paris, Paris, France., Triebwasser MP; Division of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Rialland-Battisti F; Pediatric Onco-Hematology Department, Centre Hospitalier Universitaire de Nantes, Nantes, France., Costedoat Chalumeau N; Internal Medicine, Cochin Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) Centre, Université de Paris, Paris, France., Quartier P; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM Unité Mixte de Recherche (UMR) 1163, Institut Imagine, Université de Paris, Paris, France.; Department of Paediatric Immuno-Haematology and Rheumatology, Reference Center for Rheumatic, AutoImmune and Systemic Diseases in Children, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Tangye SG; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia; and., Fleisher TA; Immunology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Rezaei N; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.; Network of Immunity in Infection, Malignancy and Autoimmunity, Universal Scientific Education and Research Network, Tehran, Iran., Romberg N; Division of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Latour S; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, INSERM UMR 1163, Institut Imagine, Université de Paris, Paris, France., Varjosalo M; Proteomics Unit, Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland., Halbritter F; St. Anna Children's Cancer Research Institute, Vienna, Austria., Rieux-Laucat F; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM Unité Mixte de Recherche (UMR) 1163, Institut Imagine, Université de Paris, Paris, France., Castanon I; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria., Rosenzweig SD; Immunology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Boztug K; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.; St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Publikováno v: Blood advances [Blood Adv] 2022 Apr 12; Vol. 6 (7), pp. 2444-2451.

Author Correction: Genotypic characterization of multiple drug resistant Escherichia coli isolates from a pediatric cancer hospital in Egypt.

Autor: Hassan R; Molecular Microbiology Unit, Children's cancer hospital Egypt 57357, Cairo, Egypt.; Department of clinical pathology, Faculty of Medicine, Cairo University, Cairo, Egypt., Tantawy M; Genomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt., Gouda NA; Genomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt., Elzayat MG; Genomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt., Gabra S; Genomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt., Nabih A; Genomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt., Diab AA; Genomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt., El-Hadidi M; Bioinformatics Group, Center of Informatics Sciences (CIS), Nile University, Giza, Egypt., Bakry U; Genomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt., Shoeb MR; Genomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt., Elanany M; Department of clinical pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.; Microbiology Unit, Children's cancer hospital Egypt 57357, Cairo, Egypt., Shalaby L; Infectious disease unit, Children's cancer hospital Egypt 57357, Cairo, Egypt.; Department of pediatric oncology, National cancer Institute, Cairo University, Cairo, Egypt., Sayed AA; Genomics Program, Children's cancer hospital Egypt 57357, Cairo, Egypt. ahmad.sayed@57357.org.; Department of Biochemistry, Faculty of Science, Ain Shams University, Cairo, Egypt. ahmad.sayed@57357.org.

Publikováno v: Scientific reports [Sci Rep] 2020 Apr 29; Vol. 10 (1), pp. 7415. Date of Electronic Publication: 2020 Apr 29.